AzTrials
AzTrials

Dental CrowdingNCT07591454

Treatment Outcome of Elastomeric and Nickel-Titanium Separators in Tooth Separation

A study testing Elastomeric separators and Nickel-Titanium separators in people with Dental Crowding and Malocclusion, Angle Class I, run by 3D-Aligners.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Patients seeking fixed orthodontic treatment that requires band placement will be enrolled in this study. This trial aims to compare the efficiency of rectangular cross-section nickel-titanium separators with elastomeric separators in creating sufficient interdental space for orthodontic band placement. Read more about this study

Who is it for?
Ages 16 to 25 years
Conditions the study is for
Dental Crowding, Malocclusion, Angle Class I
What is being tested?
Elastomeric separators and Nickel-Titanium separators
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
1 Jun 2026to 1 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Class I skeletal and dental malocclusion.
  • No history of previous orthodontic treatment.
  • All permanent teeth in both arches, except third molars.
  • Good oral hygiene and periodontal health.
  • Good interproximal tooth contacts at the site of separator placement as
  • checked by interdental floss.
  • No caries or restorations on the proximal surfaces of first and second permanent molars, and second premolars.

Who cannot join

  • Patients presenting with restorations or carious lesions on the proximal surfaces of the first or second molars or the second premolars.
  • Patients with uncontrolled gingival or periodontal inflammation.
  • Patients with a history of previous orthodontic treatment.
  • Patients are skeletally classified as Class II or Class III.
  • Patients are currently using opioid analgesics or have chronic pain conditions requiring regular analgesic intake.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Aghiad Abdalrazzak contact

+963931647613

aghiad900@gmail.com

About this study

Official title: Comparison Between The Efficiency Of Elastomeric And Nickel-Titanium Separators In Tooth Separation, Pain Perception, And Gingival Inflammation - A Randomized Controlled Trial

Patients seeking fixed orthodontic treatment that requires band placement will be enrolled in this study. This trial aims to compare the efficiency of rectangular cross-section nickel-titanium separators with elastomeric separators in creating sufficient interdental space for orthodontic band placement. In addition, the impact of both separator types on pain perception and gingival health during a 3-day placement period will be evaluated. Participants will be allocated to two groups in a split-mouth design. On the experimental side, nickel-titanium separators will be used, while elastomeric separators will be used as the control on the other side. Outcomes will include separation efficacy, pain perception over time, gingival inflammation, analgesic consumption, and separator loss.

Read the detailed description

In fixed orthodontic therapy, placement of separators is usually the first clinical step to create interdental space between posterior teeth, particularly the first molars, in preparation for orthodontic band placement. Failure to adequately separate teeth prior to banding may result in enamel damage, distortion of the band material, soft tissue injury, and increased patient discomfort. Improper band placement without sufficient separation can also lead to excessive pressure on the periodontal ligament (PDL), a risk of alveolar bone contact, and the formation of hyalinized areas within the PDL, evoking a pain response from resident mechanoreceptors. Pain is one of the primary reasons for patient dissatisfaction and discontinuation of orthodontic treatment. Therefore, identifying an ideal orthodontic separator that can produce adequate tooth separation while minimizing pain, discomfort, and gingival inflammation is of considerable clinical importance.

Being tested
Elastomeric separators, Nickel-Titanium separators
Keywords
Orthodontic separators, Nickel-Titanium, Elastomeric, Tooth separation, Pain perception, VAS, Gingival inflammation
Medical subject headings
Crowding, Malocclusion, Angle Class I, Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Elastomeric separatorsOther

    application of the elastomeric separators before application of the orthodontic bands on the first molars

  • Nickel-Titanium separatorsOther

    application of the Nickel-Titanium separators before application of the orthodontic bands on the first molars

Study groups in NCT07591454
Study groupRoleWhat they receive
Nickle-titanium groupExperimentalNot described
Receives: Other: Nickel-Titanium separators
elastomeric groupActive comparatorNot described
Receives: Other: Elastomeric separators

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Perception

    Pain perception will be assessed using a Visual Analogue Scale (VAS) and a standardized questionnaire. Patients will receive a pain perception worksheet containing a 100 mm horizontal VAS line for each side of the mouth. The scale will range from "no pain" to "worst pain imaginable" and will be completed during rest, biting, chewing, work/school activities, and sleep

    Measured: At 4, 24, 48, and 72 hours after separator placement.

  2. Separation efficacy

    Interdental separation will be measured at the time of separator removal using a feeler gauge. A separation greater than 0.16 mm will be considered sufficient for band placement, while a separation of less than 0.16 mm will be considered insufficient.

    Measured: At 72 hours after separator placement, at the time of separator removal

  3. Gingival inflammation

    Gingival inflammation will be assessed using the Löe Gingival Index. Scores will range from Grade 0 (healthy gingiva) to Grade 3 (severe gingivitis with spontaneous bleeding and ulceration).

    Measured: At baseline, before separator placement, and immediately before separator removal, 72 hours after separator placement

Secondary outcomes (2)
  1. Analgesic usage

    Participants may take ibuprofen (400 mg) as needed for pain relief. Analgesic consumption will be recorded using a standardized patient worksheet, including the time of intake, dosage, and the arch side associated with the pain.

    Measured: At 72 hours after separator placement.

  2. Separator loss

    Separator loss will be recorded clinically at the follow-up visit. A separator is considered lost if it was absent at the time of scheduled removal. Loss events are documented for each side separately.

    Measured: At 72 hours after separator placement.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 May 2026
  2. Study start1 Jun 2026 (estimated)
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion1 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07591454
Sponsor's protocol ID
UDDS-0012-2026PG/SRC1542
Status last verified
Mar 2026
First submitted
8 Mar 2026
Last updated
15 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be publicly shared because the dataset contains sensitive clinical and radiographic information, and participants did not provide consent for public sharing of individual-level data. De-identified aggregate results will be reported in the study publication.

Questions about this trial

What is this clinical trial studying?

A study testing Elastomeric separators and Nickel-Titanium separators in people with Dental Crowding and Malocclusion, Angle Class I, run by 3D-Aligners.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 15 May 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aghiad Abdalrazzak (+963931647613, aghiad900@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Perception (time frame: At 4, 24, 48, and 72 hours after separator placement.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in